Sharps Technology Inc. (STSSW)
0.05
0.02 (44.51%)
At close: Jan 15, 2025, 11:43 AM
Company Description
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.
It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications.
The company was incorporated in 2017 and is based in Melville, New York.
Sharps Technology Inc.
| Country | United States |
| IPO Date | Apr 14, 2022 |
| Industry | Financial - Capital Markets |
| Sector | Financial Services |
| Employees | 57 |
| CEO | Robert M. Hayes |
Contact Details
Address: 105 Maxess Road Melville, New York United States | |
| Website | https://sharpstechnology.com |
Stock Details
| Ticker Symbol | STSSW |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001737995 |
| CUSIP Number | 82003F119 |
| ISIN Number | US82003F1194 |
| Employer ID | 82-3751728 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert M. Hayes | Chief Executive Officer & Director |
| Ben Scheu | Senior Director of Sales |
| Dr. Steven Hertz M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 10, 2025 | S-1 | Filing |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 23, 2024 | S-3 | Filing |
| Dec 09, 2024 | 253G3 | Filing |
| Dec 06, 2024 | 4/A | [Amend] Filing |
| Dec 06, 2024 | 8-K | Current Report |
| Dec 05, 2024 | 4 | Filing |
| Dec 05, 2024 | 8-K | Current Report |
| Dec 05, 2024 | 8-K | Current Report |
| Dec 04, 2024 | 1-A-W | Filing |